In a recent online interview by the Pharma IQ Division of the International Quality & Productivity Center , James L. Sherley, M.D., Ph.D., the Director of the Adult Stem Cell Technology Center, LLC discussed the state of technology for drug evaluations for stem cell toxicity. As an expert on the topic, Dr. Sherley emphasized that, currently, few technologies exist for screening-out drug candidates that will ultimately fail as medicines due to toxicity against stem cells in the body.
http://ift.tt/1wToMAV
http://ift.tt/1wToMAV
No comments:
Post a Comment